Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

08Aug 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022

01Aug 2022

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022


Financial Calendar

08Aug 2022

Amphastar Second Quarter Earnings Call

Add to Calendar
08Jun 2022

Jefferies Healthcare Conference

Add to Calendar
09May 2022

Amphastar First Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.